We found differential expression pattern of Bcl-2 and Bcl-XL in the human breast cancer tissues and present evidences for the inhibitory effects of Bcl-XL, but not Bcl-2, on the TRAIL-induced apoptosis of tumour cell lines. Here, BCL2L1 is linked to breast cancer.